P/E ratio for Humana (HUM)
P/E ratio as of April 2024 (TTM): 12.9
According to Humana's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 12.8522. At the end of 2022 the company had a P/E ratio of 23.1.
P/E ratio history for Humana from 2001 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | 23.1 | 13.61% |
| 2021 | 20.4 | 26.31% |
| 2020 | 16.1 | -11.32% |
| 2019 | 18.2 | -22.36% |
| 2018 | 23.4 | 58.41% |
| 2017 | 14.8 | -70.24% |
| 2016 | 49.6 | 137.21% |
| 2015 | 20.9 | 8.11% |
| 2014 | 19.4 | 45.9% |
| 2013 | 13.3 | 46.15% |
| 2012 | 9.08 | -11.2% |
| 2011 | 10.2 | 22.51% |
| 2010 | 8.34 | 17.88% |
| 2009 | 7.08 | -26.32% |
| 2008 | 9.61 | -36.34% |
| 2007 | 15.1 | -18.96% |
| 2006 | 18.6 | -34.53% |
| 2005 | 28.4 | 67.66% |
| 2004 | 17.0 | 4.69% |
| 2003 | 16.2 | 37.75% |
| 2002 | 11.8 | -30.15% |
| 2001 | 16.8 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Centene CNC | 16.9 | 31.73% | 🇺🇸 USA |
 Cigna CI | 19.9 | 54.46% | 🇺🇸 USA |
 UnitedHealth UNH | 21.2 | 64.72% | 🇺🇸 USA |
 Molina Healthcare
MOH | 21.8 | 69.67% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.